Effective cytotoxicity mediated by a bispecific single-chain antibody directed against EpCAM/CD3 and cytokine-induced killer cells (CIK).

被引：0
|
作者：
Flieger, D
Kufer, P
Beier, I
Sauerbruch, T
Schmidt-Wolf, I
机构：
[1] Univ Bonn, Med Klin & Poliklin 1, D-53105 Bonn, Germany
[2] Univ Munich, LMU, Inst Immunol, D-80336 Munich, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
111
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [31] Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133high cancer stem cells in vitro and in vivo
    Huang, Jianhua
    Li, Chonghui
    Wang, Yao
    Lv, Haiyan
    Guo, Yelei
    Dai, Hanren
    Wicha, Max S.
    Chang, Alfred E.
    Li, Qiao
    CLINICAL IMMUNOLOGY, 2013, 149 (01) : 156 - 168
  • [32] A Single-Chain Variable Fragment Antibody/Chemokine Fusion Protein Targeting Human Endoglin to Enhance the Anti-Tumor Activity of Cytokine-Induced Killer Cells
    Lin, Xuandong
    Li, Haixia
    Li, Xi
    Yang, Xiaomei
    Shi, Wei
    Ding, Ziqiang
    Zhong, Dani
    Li, Yangzi
    Yang, Wenli
    Yu, Xia
    Xie, Shenxia
    Jiang, Xiaobing
    Lu, Xiaoling
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2021, 17 (08) : 1574 - 1583
  • [33] Construction and functional analysis of an anti-human cervical carcinoma/anti-human CD3 single-chain bispecific antibody
    Wu, Hong
    Yao, Li
    Chou, Lin
    Yang, Jin-Hua
    Zhang, Yun-Xiu
    Li, Xiao-Li
    Shan, Bo-Er
    MOLECULAR MEDICINE REPORTS, 2016, 14 (01) : 804 - 810
  • [34] Anti-CD3 X anti-1D10 bispecific antibody retargets and enhances the cytotoxicity of cytokine induced killer cells.
    Wang, ZH
    Lu, PH
    Weiner, GJ
    Tso, J
    Negrin, RS
    BLOOD, 1996, 88 (10) : 1253 - 1253
  • [35] A recombinant bispecific single-chain Fv antibody against HLA class II and FcγRIII (CD16) triggers effective lysis of lymphoma cells
    Bruenke, J
    Fischer, B
    Barbin, K
    Schreiter, K
    Wachter, Y
    Mahr, K
    Titgemeyer, F
    Niederweis, M
    Peipp, M
    Zunino, SJ
    Repp, R
    Valerius, T
    Fey, GH
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (02) : 167 - 179
  • [36] Characterization of an anti-human ovarian carcinomaxanti-human CD3 bispecific single-chain antibody with an albumin-original interlinker
    Fang, M
    Zhao, R
    Yang, Z
    Zhang, Z
    Li, H
    Zhang, XT
    Lin, Q
    Huang, HL
    GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 135 - 146
  • [37] Some characteristics and purification of anti-(human ovarian carcinoma) x anti-(human CD3) single-chain bispecific antibody
    Zhou, Feng
    Wei, Dong-Zhi
    Tong, Wang-Yu
    Zhu, Yi-Qi
    Jiang, Yun-Mei
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2007, 47 : 39 - 47
  • [38] T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent
    Gruen, M
    Bommert, K
    Bargou, RC
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (07) : 625 - 632
  • [39] T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent
    Michael Gruen
    Kurt Bommert
    Ralf C. Bargou
    Cancer Immunology, Immunotherapy, 2004, 53 : 625 - 632
  • [40] Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct
    Hoffmann, P
    Hofmeister, R
    Brischwein, K
    Brandl, C
    Crommer, S
    Bargou, R
    Itin, C
    Prang, N
    Baeuerle, PA
    INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (01) : 98 - 104
12345